Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

NCT00720031 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nantes University Hospital